Mode
Text Size
Log in / Sign up

Oncology

1582 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Naringenin exhibits anti-inflammatory and immunomodulatory activities in pancreatic cancer models
Oncology Sys. Review
Naringenin exhibits anti-inflammatory and immunomodulatory activities in pancreatic cancer models Naringenin Shows Potential for Managing Pancreatic Cancer Cells
This narrative review explores the biological effects of Naringenin in the context of pancreatic cancer. The authors synthesize evidence reg…
Naringenin may offer new ways to manage the complex environment of pancreatic cancer, potentially acting as a support for traditional treatm…
Dual malignant components in carcinoma ex pleomorphic adenoma demand IHC and FISH for diagnosis
Oncology Sys. Review
Dual malignant components in carcinoma ex pleomorphic adenoma demand IHC and FISH for diagnosis Specialized testing helps identify complex dual malignant tumor components
This is a case report of 2 patients with carcinoma ex pleomorphic adenoma in which both cases showed two malignant components. Histopatholog…
Doctors are using advanced staining and genetic testing to identify complex dual malignant components in rare salivary gland tumors.
Renal autotransplantation with ex vivo bench surgery preserves kidney in hilar pheochromocytoma
Oncology Sys. Review
Renal autotransplantation with ex vivo bench surgery preserves kidney in hilar pheochromocytoma New kidney preservation method shows promise for a rare tumor
This case report and literature review describes a 37-year-old man with left adrenal pheochromocytoma treated with renal autotransplantation…
A new surgical technique may help patients keep their kidneys while removing a rare tumor near the renal vessels.
Novel TCEB1 variants identified in a case of renal cell carcinoma via NGS and IHC
Oncology Sys. Review
Novel TCEB1 variants identified in a case of renal cell carcinoma via NGS and IHC Single Case Ties Rare TCEB1 Mutation to Kidney Cancer
This case report and literature review describes the identification of two somatic TCEB1 variants in a patient with a left renal mass. The f…
A 52-year-old man's kidney tumor carried a never-before-reported TCEB1 mutation, a finding that may help doctors spot this rare cancer type.
FDA Approves Jemperli (dostarlimab) for dMMR Solid Tumors and Endometrial Cancer
Oncology FDA Approval
FDA Approves Jemperli (dostarlimab) for dMMR Solid Tumors and Endometrial Cancer FDA approves new immunotherapy drug for certain advanced solid tumors
The FDA granted accelerated approval to dostarlimab (Jemperli) for adults with mismatch repair deficient (dMMR) recurrent or advanced solid …
The FDA has approved a new drug called Jemperli (dostarlimab) for adults with certain advanced or recurrent solid tumors that have a specifi…
Multimodal therapy including cytoreductive surgery and serplulimab may manage non-signet-ring cell ovarian metastases
Oncology Sys. Review
Multimodal therapy including cytoreductive surgery and serplulimab may manage non-signet-ring cell ovarian metastases New Treatment Strategy Shows Promise for Rare Colorectal Cancer Case
This case report and literature review describes a 54-year-old female with ascending colon adenocarcinoma and bilateral ovarian metastatic a…
A new multimodal approach combining surgery, chemotherapy, and immunotherapy may help manage rare cases of colorectal cancer that spread to …
ICI-based therapy may improve overall survival in patients with primary pulmonary choriocarcinoma
Oncology Sys. Review
ICI-based therapy may improve overall survival in patients with primary pulmonary choriocarcinoma Immunotherapy may extend life for men with rare lung cancer
This case report and literature review examines the management of primary pulmonary choriocarcinoma in a male patient. The authors suggest t…
A rare and aggressive lung cancer in men is showing signs of better survival when treated with immunotherapy drugs.
Multimodal exercise and physical rehabilitation provide first-line adjunctive relief for chemotherapy-induced peripheral neuropathy
Oncology Meta-analysis
Multimodal exercise and physical rehabilitation provide first-line adjunctive relief for chemotherapy-induced peripheral neuropathy New ways to manage nerve pain from chemotherapy treatments
This narrative review evaluates non-pharmacological interventions for chemotherapy-induced peripheral neuropathy (CIPN). The authors conclud…
Cancer patients facing nerve damage from chemotherapy may find relief through exercise, cold therapy, and acupuncture.
Neoadjuvant apatinib-based regimens achieve 93% R0 resection rate in resectable gastric and esophageal junction cancers
Oncology Meta-analysis
Neoadjuvant apatinib-based regimens achieve 93% R0 resection rate in resectable gastric and esophageal junction cancers Apatinib shows promise for patients with gastric and esophageal cancer
This single-arm meta-analysis of 975 patients evaluated neoadjuvant apatinib-based regimens for resectable gastric and gastroesophageal junc…
A new look at treatment data shows apatinib may help shrink tumors before surgery for patients with gastric and esophageal junction cancers.
Antibiotics Alone Fail to Improve Granulomatous Lobular Mastitis in Accessory Breast Tissue
Oncology Sys. Review
Antibiotics Alone Fail to Improve Granulomatous Lobular Mastitis in Accessory Breast Tissue Antibiotics Alone May Not Help This Breast Condition
This case report and literature review describes a patient with granulomatous lobular mastitis involving accessory breast tissue in whom ant…
A rare breast condition in accessory breast tissue did not improve much with antibiotics alone, according to a new case report.
Low CALLY Index Linked to Worse Survival in Lung Cancer, but Evidence Certainty Is Low
Oncology Meta-analysis
Low CALLY Index Linked to Worse Survival in Lung Cancer, but Evidence Certainty Is Low New blood marker may help predict lung cancer survival
This meta-analysis examined the C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic marker in patients with primary lung mal…
A specific blood marker called the CALLY index may help doctors predict how long patients with lung cancer will live.
FDA Approves Methotrexate Preservative Free for Multiple Neoplastic and Inflammatory Indications
Oncology FDA Approval
FDA Approves Methotrexate Preservative Free for Multiple Neoplastic and Inflammatory Indications FDA Approves Preservative-Free Methotrexate for Cancer, Arthritis, and Psoriasis
The FDA has approved preservative-free methotrexate injection for a range of neoplastic diseases, rheumatoid arthritis, polyarticular juveni…
The FDA approved a preservative-free form of methotrexate injection. It treats several cancers, rheumatoid arthritis, juvenile arthritis, an…